U.S. License Holder:
Auxilium Pharms.
Date of License:
February-02-2010
Last Update:
May-31-2023
FDA-Approved Indications
XIAFLEX (collagenase clostridium histolyticum) is a combination of bacterial collagenases indicated for:
The treatment of adult patients with Dupuytren's contracture with a palpable cord;
The treatment of adult men with Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.